Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into a consulting agreement effective as of September 27, 2016 with Brisco Capital Partners Corp. (“Brisco Capital”) for the provision of investor relation services.
Brisco Capital will initiate and maintain contact with the financial community, shareholders, investors and other stakeholders for the purpose of increasing awareness of CVR Medical and its activities. The agreement between CVR Medical and Brisco Capital is for an ongoing basis that may be terminated by either party by 30 days of written notice and is subject to acceptance from the TSX Venture Exchange. Brisco Capital will receive a monthly retainer of $6,500 plus applicable taxes at the start of each month, plus expenses. In addition, CVR Medical has granted an aggregate of 350,000 incentive stock options with an exercise price of $0.21. The stock options will vest immediately upon grant and the common shares issuable upon exercise will be subject to a four-month hold period. The 350,000 stock options granted to Brisco Capital are part of the aggregate 6,000,000 stock options that were previously granted and announced by news release on September 15, 2016.